Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Ginkgo Bioworks Holdings Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
DNA
New York
8731
https://investors.ginkgobioworks.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Ginkgo Bioworks Holdings Inc
Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products
- Apr 16th, 2024 11:02 am
Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets
- Apr 11th, 2024 11:01 am
Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces "Lab Data as a Service"
- Apr 11th, 2024 11:01 am
Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain
- Apr 10th, 2024 11:02 am
Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles Outbreaks
- Apr 10th, 2024 11:01 am
IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service
- Apr 8th, 2024 11:00 am
Ginkgo Bioworks to Host 5th Annual Ferment Conference
- Apr 4th, 2024 11:01 am
Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing
- Apr 3rd, 2024 11:02 am
Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets to Strengthen Next-Gen CAR Designs
- Apr 2nd, 2024 11:02 am
Ginkgo Bioworks Awarded DARPA Funding to Produce Novel Proteins to Control Ice in Extreme Cold Weather Environments
- Mar 28th, 2024 11:02 am
AQUA Cultured Foods Partners with Ginkgo Bioworks to Optimize Alt-Seafood Production
- Mar 27th, 2024 11:02 am
Imagindairy and Ginkgo Bioworks Collaborate to Develop and Produce Animal-Free Non-Whey Dairy Proteins
- Mar 26th, 2024 11:02 am
CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago
- Mar 12th, 2024 11:01 am
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2023 Financial Results
- Feb 29th, 2024 10:01 pm
bit.bio Announced as Inaugural Partner of Ginkgo Bioworks’ New Technology Network
- Feb 28th, 2024 12:12 pm
Ginkgo Bioworks Provides Compensation Information Related to Recent Acquisitions
- Feb 28th, 2024 12:03 pm
Ginkgo Bioworks Acquires Reverie Labs Platform, Enhancing AI-Driven Drug Discovery Capabilities for Customer Programs
- Feb 28th, 2024 12:02 pm
Ginkgo Bioworks Acquires Patch Biosciences, Expanding Suite of Genetic Medicine Capabilities Available to Customers
- Feb 28th, 2024 12:02 pm
Ginkgo Bioworks Acquires Proof Diagnostics, Growing Gene Editing Service Offerings for its Customers
- Feb 28th, 2024 12:02 pm
Ginkgo Technology Network Launches, Providing an Integrated R&D Experience with Capabilities from Over 25 Inaugural Partners
- Feb 28th, 2024 12:01 pm
Scroll